Overview
Here are the top health stories for the day:
1 crore refunded to patients overcharged for Covid treatment at private hospitals
The civic administration has helped over 140 patients to get a refund of Rs 1 crore who had complained of excessive charges by private hospitals in Pune for Covid-19 and mucormycosis treatment.
Patients who lodged complaints were refunded the amount after the civic bodies issued notices to the hospitals. The administration also audited bills issued to patients who underwent Covid treatment.
MUZAFFARNAGAR: Years after the woman got her ovaries removed, MRI report shows them 'fine'
A woman from Muzaffarnagar, Uttar Pradesh filed a complaint against renowned pathology lab for the misleading report which stated her ovaries are fine and without any swelling. But according to the woman, she had gotten her ovaries removed earlier. Since then the pathology labs of Muzaffarnagar, Uttar Pradesh have been under police radar.
Shocked over the report, the woman along with her husband approached a police station, claiming a city-based renowned pathology lab is doing fraud with patients. the victim stated in the complaint THAT "I had got my ovaries removed a few years back. Then, how come they are fine and shown in the MRI report? This is a fraud,".
JBCPL gets trademark assignment of HF drug Azmarda from Novartis for Rs 246 crores
JB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda indicated for heart failure patients with reduced ejection fraction (HFrEF) from Novartis AG, Switzerland for India.
Azmarda is a brand of sacubitril/valsartan, the first-in-class angiotensin receptor neprilysin inhibitor (ARNI) presently approved for the treatment of heart failure with reduced ejection fraction (HFrEF).
For more information check out the full story on the link below:
JBCPL Gets Trademark Assignment Of HF Drug Azmarda From Novartis For Rs 246 Crores
Sleeping with even low light is harmful for health: Study
According to Northwestern University researchers, even dim light can increase insulin resistance and harm cardiovascular function during sleep the following morning.
"The results from this study demonstrate that just a single night of exposure to moderate room lighting during sleep can impair glucose and cardiovascular regulation, which are risk factors for heart disease, diabetes, and metabolic syndrome, said Dr. Phyllis Zee, chief of sleep medicine at the University's Feinberg School of Medicine.